Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
Copenhagen University Hospital · University of Copenhagen · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
776
total citations
- FWCI
- 84.02
- Percentile
- 100%
- References
- 24
Citations per year
Authors
6- MRMichael R. LassenCorresponding
Copenhagen University Hospital, University of Copenhagen
- GEGary E. Raskob
University of Oklahoma Health Sciences Center
- AGAlexander Gallus
South Australia Pathology, Flinders University, Flinders Medical Centre
- GFGraham F. Pineo
University of Calgary
- DCDalei Chen
Bristol-Myers Squibb (United States)
Topics & keywords
Topics
Keywords
- Apixaban
- Medicine
- Deep vein
- Pulmonary embolism
- Knee replacement
- Surgery
- Enoxaparin sodium
- Adverse effect
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.